These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 19929206
21. Formulation development of oral controlled release tablets of hydralazine: optimization of drug release and bioadhesive characteristics. Singh B, Pahuja S, Kapil R, Ahuja N. Acta Pharm; 2009 Mar; 59(1):1-13. PubMed ID: 19304554 [Abstract] [Full Text] [Related]
22. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium. Savaşer A, Ozkan Y, Işimer A. Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476 [Abstract] [Full Text] [Related]
23. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation. Nabais T, Brouillet F, Kyriacos S, Mroueh M, Amores da Silva P, Bataille B, Chebli C, Cartilier L. Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270 [Abstract] [Full Text] [Related]
24. Study of formulation variables influencing the drug release rate from matrix tablets by experimental design. Furlanetto S, Cirri M, Maestrelli F, Corti G, Mura P. Eur J Pharm Biopharm; 2006 Jan; 62(1):77-84. PubMed ID: 16154333 [Abstract] [Full Text] [Related]
25. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone. Hardy IJ, Windberg-Baarup A, Neri C, Byway PV, Booth SW, Fitzpatrick S. Int J Pharm; 2007 Jun 07; 337(1-2):246-53. PubMed ID: 17306477 [Abstract] [Full Text] [Related]
26. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets]. Li X, Feng Z, Huo W, Li Y, Wang B, Zhu S. Zhongguo Zhong Yao Za Zhi; 2009 May 07; 34(10):1216-9. PubMed ID: 19673379 [Abstract] [Full Text] [Related]
29. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. Ceballos A, Cirri M, Maestrelli F, Corti G, Mura P. Farmaco; 2005 May 07; 60(11-12):913-8. PubMed ID: 16129436 [Abstract] [Full Text] [Related]
30. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. Varshosaz J, Tavakoli N, Kheirolahi F. AAPS PharmSciTech; 2006 Mar 17; 7(1):E24. PubMed ID: 16584155 [Abstract] [Full Text] [Related]
31. The effect of processing variables on the mechanical and release properties of tramadol matrix tablets incorporating Cissus populnea gum as controlled release excipient. Adeleye OA, Femi-Oyewo MN, Odeniyi MA. Polim Med; 2014 Mar 17; 44(4):209-20. PubMed ID: 25932902 [Abstract] [Full Text] [Related]
32. Evaluation of Prosopis africana Seed Gum as an Extended Release Polymer for Tablet Formulation. Nadaf S, Nnamani P, Jadhav N. AAPS PharmSciTech; 2015 Jun 17; 16(3):716-29. PubMed ID: 25523143 [Abstract] [Full Text] [Related]
33. Sustained delivery of captopril from floating matrix tablets. Jiménez-Martínez I, Quirino-Barreda T, Villafuerte-Robles L. Int J Pharm; 2008 Oct 01; 362(1-2):37-43. PubMed ID: 18588962 [Abstract] [Full Text] [Related]
36. Polymers derived from Xanthomonas campesteris and Cyamopsis tetragonolobus used as retardant materials for the formulation of sustained release floating matrix tablet of atenolol. Dey S, Mazumder B, Chattopadhyay S, Das MK, Sinha S, Ganguly S, De K, Mishra M. Int J Biol Macromol; 2014 Apr 01; 65():346-56. PubMed ID: 24472506 [Abstract] [Full Text] [Related]